Sarah Lebeer is a Full Professor in Microbiology at the University of Antwerp and a globally recognized expert in lactobacilli, probiotics, the microbiome, and women's health. She leads the Laboratory of Applied Microbiology and Biotechnology (LAMB), where her interdisciplinary research explores the ecological and functional roles of beneficial microbes in mucosal environments. From 2019 to 2025, she held a ERC Starting Grant on advancing lactobacilli' beneficial potential, and she currently coordinates the ERC Proof of Concept project VALERIE, which focuses on microbiome-based innovations for women's health. Her work bridges fundamental microbiology with translational applications in health equity and sustainable biotechnology.
- Papers in database
- 16
- Primary author
- 2 papers
- Years active
- 2007 – 2024
- Total publications
- 306
- Total citations
- 26,314
- h-index
- 64
Research Areas
- Probiotics and Fermented Foods
- Gut microbiota and health
- Microbial Metabolites in Food Biotechnology
- Reproductive tract infections research
- Glycosylation and Glycoproteins Research
Papers (16)
- 2024Positioning the preventive potential of microbiome treatments for cystic fibrosis in the context of current therapies.10.1016/j.xcrm.2023.101371
- 2022Randomized, Double-Blind, Placebo-Controlled Trial of a Throat Spray with Selected Lactobacilli in COVID-19 Outpatients.10.1128/spectrum.01682-22
- 2022Spontaneous Riboflavin-Overproducing Limosilactobacillus reuteri for Biofortification of Fermented Foods10.3389/fnut.2022.916607
- 2020A taxonomic note on the genus Lactobacillus: Description of 23 novel genera, emended description of the genus Lactobacillus Beijerinck 1901, and union of Lactobacillaceae and Leuconostocaceae.10.1099/ijsem.0.004107
- 2020Strain-specific differences in behaviour among Lacticaseibacillus rhamnosus cell wall mutants during direct compression.10.1016/j.ijpharm.2020.119755
- 2020Lacticaseibacillus rhamnosus GG inhibits infection of human keratinocytes by Staphylococcus aureus through mechanisms involving cell surface molecules and pH reduction.10.3920/BM2020.0075
- 2019Food Supplements to Mitigate Detrimental Effects of Pelvic Radiotherapy.10.3390/microorganisms7040097
- 2018Engineering Lactobacillus rhamnosus GG and GR-1 to express HIV-inhibiting griffithsin.10.1016/j.ijantimicag.2018.07.013
- 2018Comparative Genomic and Phenotypic Analysis of the Vaginal Probiotic Lactobacillus rhamnosus GR-110.3389/fmicb.2018.01278
- 2017Large-Scale Phylogenomics of the Lactobacillus casei Group Highlights Taxonomic Inconsistencies and Reveals Novel Clade-Associated Features10.1128/mSystems.00061-17
- 2017Interplay between Lactobacillus rhamnosus GG and Candida and the involvement of exopolysaccharides10.1111/1751-7915.12799
- 2016The lectin-like protein 1 in Lactobacillus rhamnosus GR-1 mediates tissue-specific adherence to vaginal epithelium and inhibits urogenital pathogens10.1038/srep37437
- 2015Lactobacillus species as biomarkers and agents that can promote various aspects of vaginal health10.3389/fphys.2015.00081
- 2015Towards a better understanding of Lactobacillus rhamnosus GG - host interactions10.1186/1475-2859-13-S1-S7
- 2012Primary authorFunctional Analysis of Lactobacillus rhamnosus GG Pili in Relation to Adhesion and Immunomodulatory Interactions with Intestinal Epithelial Cells10.1128/AEM.06192-11
- 2007Primary authorImpact of Environmental and Genetic Factors on Biofilm Formation by the Probiotic Strain Lactobacillus rhamnosus GG10.1128/AEM.01393-07